Transplants for MDS and Severe Aplastic Anemia - 2023 Omaha Patient and Family Hybrid Conference @AAMDSIF
Transplants for MDS and Severe Aplastic Anemia - 2023 Omaha Patient and Family Hybrid Conference @AAMDSIF
Uploaded June 2026 | Updated September 2026, 2 days ago
This session explains why and how patients may be offered a transplant to treat MDS, or myelodysplastic syndromes, or severe aplastic anemia. Dr. Gundabolu also answers questions from the live audience.
#aplasticanemia #mds #bonemarrowtransplant
To find more content like this, please visit the website, aamds.org, or click through the links below.
aamds.org/webinar/ask-transplant-expert
aamds.org/webinar/life-after-transplant-patient-panel-discussion
Transplants for MDS and Severe Aplastic Anemia - 2023 Omaha Patient and Family Hybrid ConferenceThe Future of Clinical Trials for Bone Marrow FailureRecent FDA Approval of Danicopan for patients with PNHTransplant for Severe Aplastic Anemia (Pediatric) - 2022 Memphis Patient & Family ConferencePanel Discussion: Addressing the Gaps in Serving Transplant PatientsPredisposition to MDS (Pediatric) - 2022 Memphis Patient and Family ConferenceBrian Anderson Explains Life, Treatment, and Surviving MDSAplastic Anemia and Non-Transplant Therapies from the 2024 New Haven Patient and Family ConferenceLong, Hard, Road to Diagnosis - Shaquillas PNH StoryMedicare Made Simple for Patients - Webinar RecordingHigh Risk MDS Non-Transplant Therapies Current Therapies and Clinical Trials 2023 OmahaMDS CLASSIFICATION & PROGNOSIS
AAMDSIF |

Transplants for MDS and Severe Aplastic Anemia - 2023 Omaha Patient and Family Hybrid Conference

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER